Author: Martinez-Banaclocha, Marcos
Title: Interfering Reactive Cysteine Proteome in Covid-19 Disease. Cord-id: e6oovlv6 Document date: 2021_6_23
ID: e6oovlv6
Snippet: Although vaccination against SARS-CoV-2 infection has been initiated, effective therapies for severe Covid-19 disease are still needed. A promising therapeutic strategy is using FDA-approved drugs that have the biological potential to interfere with or modify some of the viral proteins capable of changing the disease's course. Recent studies highlight that some clinically safe drugs can suppress the viral life cycle while potentially promoting an adequate host inflammatory/immune response by int
Document: Although vaccination against SARS-CoV-2 infection has been initiated, effective therapies for severe Covid-19 disease are still needed. A promising therapeutic strategy is using FDA-approved drugs that have the biological potential to interfere with or modify some of the viral proteins capable of changing the disease's course. Recent studies highlight that some clinically safe drugs can suppress the viral life cycle while potentially promoting an adequate host inflammatory/immune response by interfering with the disease's cysteine proteome.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date